Disposable Endoscopes Market Size, Share & Trends Analysis Report By Application (Bronchoscopy, Urologic Endoscopy, Arthroscopy, GI Endoscopy, ENT Endoscopy), By End Use, By Region, And Segment Forecasts, 2021 - 2028

Report Overview

The global disposable endoscopes market size was valued at USD 1.3 billion in 2020 and is expected to expand at a compound annual growth rate (CAGR) of 16.9% from 2021 to 2028. Rising concern over cross-contamination due to the usage of reusable endoscopes is a major parameter driving the market. According to an article published in September 2020, one in twenty endoscopes has a pathogen of concern on them. Moreover, increasing support from medical authorities for using disposable or single-use endoscopes is supporting market growth. For instance, in December 2020, a new pass-code (C1748) was effective for providers utilizing single-use duodenoscopes in hospitals and ambulatory surgical center for treating Medicare patients in the U.S. This makes single-use duodenoscopes an economically feasible alternative to reusable duodenoscopes.

Adoption of single-use and sterile endoscopes is rapidly rising during the COVID-19 pandemic as it eliminates the possibilities of infection and enhances safety. The demand for single-use devices increased after studies confirmed the development of other hospital-acquired infections in existing COVID-19 patients. Moreover, pulmonology associations have recommended the use of single-use bronchoscopy for the prevention of infection during the COVID-19 pandemic. This in turn is estimated to drive the market growth potential.

Reusable endoscopes require massive capital expenditure. It needs to be reprocessed after each use and repaired periodically. Disposable endoscopes reduce the cost of cleaning maintenance and repair thereby saving time. Disposable endoscopes are cost-effective as compared to reusable endoscopes thereby driving the market growth potential. According to a study published in the 2019 Chest Journal, hospitals using reusable bronchoscopes pay 21% to 155% more per instrument as compared to disposable endoscopes.

Rapid advancement in technology along with investments by endoscope manufacturers for the development of new products is driving the market for disposable endoscopes. For instance, in November 2020, Olympus Corporation partnered with Ruhof Corporation introduced single-use procedure kits and hybrid tubing for endoscopes to reduce infection risks. Moreover, in November 2020, Omnivision launched imaging subsystems including camera modules, cables and image signal processor boards for disposable endoscopes.

COVID19 disposable endoscopes market impact: 27.2% increase in revenue

In May 2020, Ambu A/S introduced Ambu aView 2 Advance, a display unit for single-use endoscopes. Ambu aView 2 Advance is a mobile platform and can be used with different types of endoscopes including bronchoscope, rhinolaryngoscope, and cystoscopes among others. Thus, the development of components and visualization systems for disposable endoscopes is supporting market growth.

Key stakeholders operating in the market for disposable endoscopes are adopting various strategies such as new product development to increase the adoption of disposable endoscopes. For instance, Ambu has announced the launch of 3 new disposable endoscopes including Ambu aScope Duodeno, colonoscope, and gastroscope in 2021. In February 2019, Israeli endoscopy firm Zsquare received USD 10 million for the development of MutliPly, a single-use endoscopic platform. It comprises a flexible, ultrathin, single-use, and high-resolution endoscope that facilitates access to unserved indications and improves usability and diagnosis for common indications. Integrated Endoscopy, Inc. introduced a single-use arthroscope to tackle infection outbreaks caused due to arthroscopes in June 2015.

Application Insights

The bronchoscopy segment dominated the market for disposable endoscopes and held the largest revenue share of 29.9% in 2020. The presence of a large number of bronchoscopes and the growing prevalence of related disorders is driving the segment. According to the American Lung Association, there were 2.0 million new cases of lung cancer globally in 2018. According to the World Health Organization, globally, 65 million people were suffering from moderate to severe COPD, while 334 million people were suffering from asthma in 2017. Moreover, COPD, asthma, acute lower respiratory tract infections, tuberculosis, and lung cancer are a common cause of severe illness and death globally. The development of technologically advanced products is supporting market growth. For instance, in June 2019, Valtronic launched a disposable bronchoscope to prevent infections.

However, the ENT endoscopy segment is expected to witness significant growth over the forecast period. This is attributed to the growing adoption of disposable endoscopes ENT specialists owing to its advantages such as reduction of cross-contamination, and reduction in cleaning and service cost is driving the segment growth. Moreover, the increasing prevalence of ear, nose, and throat infections is estimated to drive the market potential. Moreover, technological development and subsequent product launches are also contributing to segment growth. For instance, in June 2020, 3NT Medical introduced Colibri Micro ENT Scope, a single-use ENT endoscope in the U.S.

End-use Insights

The hospitals segment dominated the market for disposable endoscopes and accounted for the largest revenue share of 47.8% in 2020. This is owing to the favorable reimbursement policies along with the presence of a large number of hospitals in developed and developing regions. Moreover, the large-scale adoption of endoscopes in hospitals and an increasing number of surgeries performed in hospitals are driving the segment growth. Increasing awareness of hospital-acquired infections due to contaminated medical devices such as endoscopes is also contributing to the growth of the segment.

However, the clinics segment is expected to witness a significant growth rate over the forecast period owing to the increasing adoption of disposable endoscopes by clinics due to its cost-effectiveness as compared to reusable endoscopes. Less time requirement for endoscopic procedures and quick recovery time are supporting the clinics end-use segment growth. Moreover, there is a rise in trend in same-day surgery which results in cost savings especially in the developed countries.

Regional Insights

North America dominated the disposable endoscopes market and accounted for the largest revenue share of 42.1% in 2020. This is attributed to the presence of developed infrastructure, high adoption of advanced technologies and growing awareness on minimal invasive surgeries. Moreover, a growing geriatric population and increasing prevalence of cancer, and gastrointestinal disorders among others is supporting market growth. In 2018, 22.4 million people visited physician’s office for digestive system diseases in the U.S., according to the Centers for Disease Control and Prevention. As per the National Cancer Institute’s data-sets, 1,806,590 new cases of cancer were diagnosed in 2020 in the U.S. In addition, the presence of a large number of manufacturers and suppliers and regulatory approvals for the use of reusable endoscopes is driving the market growth. For instance, in April 2020, Ambu aScope Cysto received 510k clearance from the U.S. FDA.

However, in the Asia Pacific, the market for disposable endoscopes is anticipated to witness the fastest growth rate during the forecast period. The improving healthcare infrastructure and presence of lesser regulatory frameworks are expected to drive the market in the region. Moreover, an increase in awareness about the advantages of minimally invasive surgeries over open surgeries and a rise in chronic disease burden is expected to provide growth opportunities in this region. More than half of the world’s population belongs to India and China, providing a large patient pool and elderly population, especially in China, which is expected to further drive the market in the region over the forecast period.

Key Companies & Market Share Insights

Key companies operating in the market are introducing new products in the market to cater to the growing demand for disposable endoscopes. For instance, in December 2019, Boston Scientific Corporation introduced EXALT Model D Single-Use Duodenoscope for ERCP (endoscopic retrograde cholangiopancreatography) procedures to cater to the growing demand for disposable endoscopes. Some of the prominent players in the disposable endoscopes market include:

• Ambu A/S

• Prosurg Inc. (Neoscape, Inc.)

• AirStrip Technologies

• Boston Scientific Corporation

• Parburch Medical

• OBP Medical Corporation

• Welch Allyn (Hill-Rom Services Inc.)

• Allscripts Healthcare Solutions

• Flexicare Medical Limited

• Timesco Healthcare Ltd.

• Sunmed

Disposable Endoscopes Market Report Scope 

Segments Covered in the Report

This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2016 to 2028. For the purpose of this study, Grand View Research, Inc. has segmented the global disposable endoscopes market report based on application, end-use, and region:

• Application Outlook (Revenue, USD Million, 2016 - 2028)

  • Bronchoscopy

  • Urologic endoscopy

  • Arthroscopy

  • GI endoscopy

  • ENT endoscopy

  • Others

• End-use Outlook (Revenue, USD Million, 2016 - 2028)

  • Hospitals 

  • Clinics

  • Diagnostics Centers

• Regional Outlook (Revenue, USD Million, 2016 - 2028)

  • North America

    • U.S.

    • Canada

  • Europe

    • U.K.

    • Germany

    • France

    • Italy

    • Spain

    • Russia

  • Asia Pacific

    • Japan

    • China

    • India

    • Australia

    • Thailand

  • Latin America

    • Mexico

    • Brazil

    • Argentina

  • Middle East & Africa

    • South Africa

    • Saudi Arabia

    • UAE